AEGLE THERAPEUTICS
Aegle Therapeutics is a privately-held biotechnology company developing a first in class therapy using extracellular vesicles, including exosomes, secreted by allogeneic bone marrow-derived mesenchymal stem cells. Aegle's platform technology is initially being developed to treat dystrophic epidermolysis bullosa, a rare pediatric skin blistering disorder. Aegle's IND for DEB has been cleared by the FDA and the company expects to enter the clinic by the 2H of 2020. Its proprietary platform isolati... on technology is cell-free and has the potential to demonstrate a safer, lower-cost means of harnessing the regenerative healing power of stem cells without using the cells. Aegle believes its EV therapy has the potential for functional regeneration and organization of complex tissue structures that can enhance healing, reduce scarring, minimize contraction, and improve overall cosmesis. The company was founded in 2013 and is based in Miami, Florida.
AEGLE THERAPEUTICS
Social Links:
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2013-01-01
Address:
Miami, Florida, United States
Country:
United States
Website Url:
http://www.aegletherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
13.5 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon WordPress Content Delivery Network LetsEncrypt Amazon SSL By Default HSTS
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Advisors List
Current Employees Featured
Founder
Investors List
DeepWork Capital
DeepWork Capital investment in Convertible Note - Aegle Therapeutics
DeepWork Capital
DeepWork Capital investment in Series A - Aegle Therapeutics
Ocean Azul Partners
Ocean Azul Partners investment in Series A - Aegle Therapeutics
Tellus BioVentures
Tellus BioVentures investment in Series A - Aegle Therapeutics
New World Angels
New World Angels investment in Series A - Aegle Therapeutics
DEFTA Partners
DEFTA Partners investment in Series A - Aegle Therapeutics
New World Angels
New World Angels investment in Series A - Aegle Therapeutics
Ocean Azul Partners
Ocean Azul Partners investment in Series A - Aegle Therapeutics
DeepWork Capital
DeepWork Capital investment in Series A - Aegle Therapeutics
Tellus Partners
Tellus Partners investment in Series A - Aegle Therapeutics
Official Site Inspections
http://www.aegletherapeutics.com Semrush global rank: 6.7 M Semrush visits lastest month: 1.04 K
- Host name: ec2-3-220-221-84.compute-1.amazonaws.com
- IP address: 3.220.221.84
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Aegle Therapeutics"
Company - AEGLE Therapeutics
Willistine Lenon has more than 27 years of clinical operation experience in the pharmaceutical and contract research organization (CRO) industries. Ms. Lenon’s global experience includes …See details»
AEGLE Therapeutics - Harnessing the regenerative, …
Aegle Therapeutics is a pioneer in regenerative medicine developing extracellular vesicle (EV) therapy to meaningfully improve the lives of those suffering from debilitating rare diseases, including dystrophic epidermolysis bullosa (DEB) …See details»
Aegle Therapeutics - Crunchbase Company Profile
Aegle believes its EV therapy has the potential for functional regeneration and organization of complex tissue structures that can enhance healing, reduce scarring, minimize contraction, and improve overall cosmesis. The company …See details»
Aegle Therapeutics Company Profile | Management and
Aegle Therapeutics (www.aegletherapeutics.com) is a privately held biotechnology company developing extracellular vesicles, including exosomes, secreted by mesenchymal stem cells …See details»
Aegle Therapeutics - Overview, News & Similar companies
Who is Aegle Therapeutics. Aegle Therapeutics (www.aegletherapeutics.com) is a privately held biotechnology company developing extracellular vesicles, including exosomes, sec reted by …See details»
Aegle Therapeutics
Aegle believes AGLE-102 has the potential for functional regeneration and organization of complex tissue structures in DEB patients that can accelerate and enhance healing, reduce …See details»
Aegle Therapeutics - LinkedIn
Aegle Therapeutics Corp. is a clinical-stage biotechnology company developing novel extracellular vesicle (“EV”) therapies to address rare and serious diseases and disorders with …See details»
Aegle Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Aegle Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Aegle Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
Aegle Therapeutics is a first-in-class, phase 1/2a biotechnology company isolating extracellular vesicles including exosomes ("EVs") secreted by allogeneic bone marrow derived …See details»
Aegle Therapeutics
Heidi Kempinski joined Aegle in 2020 as the Senior Vice President and Head of Operations. She is a seasoned operations executive who brings over 25 years of experience in global drug …See details»
Aegle Therapeutics | Company | Mindmaps
Aegle believes its EV therapy has the potential for functional regeneration and organization of complex tissue structures that can enhance healing, reduce scarring, minimize contraction, …See details»
Aegle Therapeutics Corporation - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Aegle Therapeutics Corporation of Woburn, MA. Get the latest business insights from Dun & Bradstreet.See details»
Aegle Therapeutics Corp. - Drug pipelines, Patents, Clinical
For more information visit www.aegletherapeutics.com . SOURCE: Aegle Therapeutics. Clinical Study. 29 Mar 2024 ... The statistics for drugs in the Pipeline is the current organization and its …See details»
Aegle Therapeutics Company Profile - Office Locations ... - Craft
Aegle Therapeutics has 1 employees at their 1 location and $10.5 m in total funding,. See insights on Aegle Therapeutics including office locations, competitors, revenue, financials, executives, …See details»
Aegle Therapeutics - Company Profile & Staff Directory - ContactOut
Aegle Therapeutics is a first-in-class, phase 1/2a biotechnology company isolating extracellular vesicles including exosomes ("EVs") secreted by allogeneic bone marrow derived …See details»
Aegle Therapeutics - Company info. interviews, news
Dec 29, 2022 Aegle Therapeutics is a first-in-class, phase 1/2a biotechnology company isolating extracellular vesicles including exosomes ("EVs") secreted by allogeneic bone marrow derived …See details»
Aegle Therapeutics | CipherBio
Explore Aegle Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Pipeline - AEGLE Therapeutics
Aegle has recently completed the successful transfer of its manufacturing from the University of Miami to a commercial contract manufacturing organization. Clinical production is anticipated …See details»
Aegle Therapeutics
Aegle Therapeutics is developing a novel technology platform using extracellular vesicles isolated from mesenchymal stem cells to deliver therapeutically significant RNA, proteins and …See details»
Aegle Therapeutics - VentureRadar
Similar Companies: SwissGenesis GmbH Switzerland Privately Held An innovative Swiss Biotech company focused on bringing innovations in biotechnology to the discovery, development and …See details»